News Focus
News Focus
Followers 112
Posts 10856
Boards Moderated 0
Alias Born 03/01/2009

Re: None

Tuesday, 01/15/2013 8:02:35 AM

Tuesday, January 15, 2013 8:02:35 AM

Post# of 6405
WoW! I haven't paid too much attention to what's going on here...
Salari left!?!
Good riddance!
He turned out to be a big disappointment!

I fear this company was just a mealticket for him...
he had a good idea, but FAILED to take it anywhere!!!

This other company is doing what Salari could NOT.
"I believe that thin-films are the big opportunity in
IntelGenx' portfolio. Whether it is drugs for erectile dysfunction, insomnia or migraine, each of
these products represent much bigger opportunities for IntelGenx than ForFivo. With Reckitt
Benckiser's suboxone film (one of only two FDA approved thin films) apparently trending toward
$1B in annual sales, it is clear that the market and FDA are receptive to this new delivery
system. Fortunately, IntelGenx has 6 thin-film drugs in its pipeline, and at least 2 of them are
scheduled for NDA filings in the next 12 months."

the 2 are
"Horst is also on record saying he expects to file an NDA for IntelGenx’s sublingual
migraine strip in Q1-2013."
and
"the company is aiming to submit a 505(b)(2)
NDA for its ‘Cialis-on-a-strip” product with the FDA during 2013"

Here is their target
"“The bottom line here is that
my target of realizing between $3/share and $8/share over the next 3-5 years seems much
more achievable in light of the series of very positive developments seen in the last 6 months.”
With the known pipeline and a launched drug, $3 seems almost easy now within the remaining
2-4 year timeframe (and I like the fact it corresponds to Ram’s target). Whether the $8 upside
potential can be realized will depend on a number of yet-to-be-known factors, not the least of
which are details about the partnership with PAR Pharmaceuticals and the drug they are codeveloping.
If the PAR partnership blossoms into something special, and/or the two companies
co-develop some drugs with truly big potential, the $5-$10 range becomes a real possibility."
http://www.northernriversfunds.com/assets/downloads/Cleland%20-%20BIPES%20Series%20A%20Sept%2030%202012.pdf
Check it out...cuz this turkey is DEAD!!

"the problem with following the herd is that your ultimate destination is the slaughterhouse" ...Chuck Carnevale

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today